Related Experiment Video
Updated: Jan 21, 2026
07:13
A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
6.9K
Diabetes, heart failure, and renal dysfunction: The vicious circles
1TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, MA, USA.
Progress in Cardiovascular Diseases
|August 5, 2019
Summary
Type 2 diabetes mellitus (T2DM) significantly increases risks for heart failure and renal dysfunction, creating dangerous cycles. Interrupting these interconnected health issues is a key therapeutic aim.
Area of Science:
- Endocrinology and Metabolism
- Cardiology
- Nephrology
Background:
- Type 2 diabetes mellitus (T2DM) prevalence is a global health crisis.
- T2DM is linked to severe macrovascular and microvascular complications.
- These complications include myocardial infarction, heart failure, stroke, and renal failure.
Purpose of the Study:
- To describe the complex interactions between T2DM, heart failure, and renal dysfunction.
- To highlight the concept of vicious circles formed by these conditions.
- To identify therapeutic goals for interrupting these detrimental cycles.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of pathophysiological mechanisms linking T2DM, heart failure, and renal dysfunction.
- Identification of common pathways and feedback loops.
Main Results:
- T2DM exacerbates both heart failure and renal dysfunction.
- Heart failure and renal dysfunction can worsen T2DM control and complications.
- These interactions form self-perpetuating vicious circles impacting survival.
Conclusions:
- Understanding the interplay between T2DM, heart failure, and renal dysfunction is crucial.
- Targeting these interconnected pathways offers significant therapeutic potential.
- Interruption of these vicious circles is a primary goal for improving patient outcomes.
Keywords:
Cardiovascular diseaseChronic kidney diseaseDiabetes mellitusDiabetic kidney diseaseHeart failureType 2 diabetes mellitusMore Related Videos
Related Concept Videos
01:11Renal Failure: Dose Adjustments
442
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
442
01:29Heart Failure II: Pathophysiology
783
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
783
01:17Pathophysiology of Heart Failure
3.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.0K
01:27Heart Failure I: Introduction
723
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
723
01:22Heart Failure VI: Adjunct Therapies
277
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
277
01:22Heart Failure Drugs: Diuretics
824
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
824